Global Vascular
Developer of a drug-eluting stent delivery system designed for the treatment of lower limb artery disease. The company's nanotechnology suppresses thrombus adhesion and allows cell integration with th...
Valuation
$50.3M
Market implied
Share Price
N/A
Total Raised
$18.8M
Last Round
N/A